Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss medication on FOX Business, saying there's "a lot of excitement." Orignial Source: https://www.foxbusiness.com/media/novo-nordisk-executive-reports-high-interest-once-daily-oral-weight-loss-pill Previous article: Former Intel CEO warns US chip comeback still has long way to go Prev Next article: Bessent signals potential Venezuela sanctions relief 'as soon as next week': report Next
